Frontlight ResearchEarly access
CompletedNo phase
Non-Invasive Monitoring of Traumatic Brain Injury Progression Using the Infrascanner (MOBI-1)
Key facts
- Who runs it
- University of Alabama at Birmingham
- Where
- Birmingham and Tucson, United StatesSee the 2 sites
- Trial code
- Status
- Completed
- People taking part
- 399 people enrolled
- Started
- 18 Apr 2022
- Ended
- 25 Aug 2025
- Type of study
- Observational
- Treatments tested
- Standard care plus infrascans
- Record updated
- 2 September 2025
Who can take part
- Age
- 15 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Age 15 or older
- Admission CT Scan shows intracranial hemorrhage
- Glasgow Coma Scale less than 15
- Neurosurgery service determines initial care is nonoperative
- Admitted for observation for TBI, to either step-down unit or intensive care unit
Who cannot take part
- Admitted and observed for >2 hours prior to screening (i.e., has already received second neurological check)
- Planned surgical interventions/ procedures during study period (before the second CT scan)
- Inability to provide informed consent or lack of a legally authorized representative (LAR)
- Other injuries deemed non-survivable
- Diagnosed with hemorrhagic shock or receives a large volume transfusion (>3 units of any blood product within any 1 hour)
- Known prisoner
Where in United States
- UAB HospitalBirmingham, United States
- University of ArizonaTucson, United States
About the trial
What the trial wants to find out
MOBI-1 is a multicenter clinical trial that will evaluate the use of the Infrascanner for the monitoring of traumatic intracranial hematomas.
The group in the trial
- Standard care plus infrascans
All participants will receive regular clinical neurological assessments as ordered by the clinical care team. In addition, a research team member will perform an infrascan. This process will be repeated hourly at the same timepoint as the clinical neurological assessments. If a patient's neurological status deteriorates at any time point, and the medical team orders an early (unplanned) CT scan, the neurological data collection will cease once the patient is sent to CT. Infrascan results will not be shared with the clinical care team, and will not guide the participants' care in any way.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 2 September 2025